scispace - formally typeset
R

Regina V. Tse

Researcher at University of Sydney

Publications -  10
Citations -  1092

Regina V. Tse is an academic researcher from University of Sydney. The author has contributed to research in topics: Cancer & Radiation therapy. The author has an hindex of 6, co-authored 10 publications receiving 1009 citations. Previous affiliations of Regina V. Tse include University of Toronto & Princess Margaret Cancer Centre.

Papers
More filters
Journal ArticleDOI

Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

TL;DR: Individualized six-fraction SBRT is a safe treatment for unresectable HCC and IHC and no radiation-induced liver disease or treatment-related grade 4/5 toxicity was seen within 3 months after S BRT.
Journal ArticleDOI

Phase I Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

TL;DR: Individualized six-fraction liver metastases SBRT is safe, with sustained local control observed in the majority of patients, according to the outcomes of a phase I study of stereotactic body radiotherapy (SBRT) for treatment of Liver metastases.
Journal ArticleDOI

Conformal radiotherapy for hepatocellular carcinoma.

TL;DR: Investigations to better understand the pathophysiology of RT-induced liver toxicity are warranted and a particular interest in combining RT with anti-VEGF-targeted agents for their independent activity in HCC as well as their radiation sensitization properties.
Journal ArticleDOI

Mutations associated with microsatellite unstable colorectal carcinomas exhibit widespread intratumoral heterogeneity.

TL;DR: It seems likely that a random accumulation of mutations, as a result of a defect in the mismatch repair pathway, drives tumour progression in this type of colorectal carcinoma.